Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Ipilimumab
×
Gastrointestinal
×
Clear all
Filters
3
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts
NCT04311710
2023-02-24
CheckMate 76U
Bristol-Myers Squibb
Phase 1
Terminated
21 enrolled